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non-proliferating (Q) cells, which may differ
in their sensitivity to drugs or ionizing
radiation. Experimental data on changes in
cell proliferation characteristics of a trans-
plantable R-1 rat rhabdomyosarcoma have
shown that the fraction of P cells may
increase and the cell cycle time may decrease
after irradiation. This has led to experiments
on the effectiveness of a cell cycle-specific
drug given at various time jntervals after
irradiation.
Growth delay of the R-1 rhabdomyo-
sarcoma was measured after doses of2000 rad
or 1000 rad of x-rays, followed at intervals of
up to 12 days by the administration of
vinblastine at a dose level of 1-5 mg/kg of
body weight. This dose of vinblastine alone
induced a growth delay of 2.5 days, while
1000 rad and 2000 rad of x-rays induced
growth delays of 7 and 15 days respectively.
Vinblastine given 8 h before irradiation gave
approximately the same effect as irradiation
only, but vinblastine given 48-192 h after
irradiation caused a very significant excess
delayofabout 8 days over that expected from
a directly additive action. This can be
ascribed to recruitment of Q cells into the
compartment ofP cells. Asimilarsynergistic
effect was observed for a rat osteosarcoma but
not for a rat skin carcinoma and a rat bladder
carcinoma.
Work supported under contract NO1-
CM-53763 by the National Cancer Institute
USA.
IN VIVO INVESTIGATIONS ABOUT
THE EFFECTS OF RADIATION
AND/OR DRUGS IN NORMAL
TISSUE AND IN SARCOMA-180. W.
PORSCHEN and L. E. FEINENDEGEN, Labora-
tory of Neutron Biology and Cellular Tumor
Kinetic, Institut fur Medizin, KFA, Julich.
An external assay has been developed and
modified in this laboratory that permits the
evaluation of the effects of radiation and/or
drugs in the living mouse. Cells are labelled
in vivo with iododeoxyuridine (1251UdR).
IUdR is an analogue of thymidine; both
precursors are specifically and rapidly incor-
porated into DNA of S cells at the time the
precursors are made available. Reutilization
of IUdR is minimal; therefore labelled
IUdR is the tracer of choice for turnover
studies. The soft y-rays from 1251 are easily
measured externally, either with the whole
body counter or with a tumour measuring
device specifically developed for assaying
solid tumours.
This paper reports on the effect of radia-
tion and/or drugs on the rate ofincorporation
of '25JUdR into whole body DNA and
tumour DNA in the living mouse. In
addition, the effect of actinomycin D on the
rate ofturnover oflabelled tumour cells in the
living mouse was assayed. Prolonged obser-
vations in the living organism with this
technique do not disturb the physiological
equilibrium, be it in normal or in tumour
bearing animals. In this study, sarcoma-180
was used as a solitary tumour growing in the
hind leg ofNMRI mice; 10-12 mice were used
per experimental point.
The incorporation of 125IUdR into whole
body DNA on one hand and tumour DNA on
the other hand was measured in the living
mice at various times after acute exposure to
y-radiation, neutron radiation or after a
single administration offluorouracil, hydroxy-
urea and actinomycin D. Each of these
treatments caused a specific effect ofdifferent
duration and the maximum effect in the
whole body surpassed that observed for the
tumour. On the other hand, a single
administration of a platinum complex
compound (cis-dichloro-diammine-platinum)
caused not only prolonged effects in the whole
body and tumour but the effects to the
tumour surpassed that of the whole body:
combined effects of actinomycin D and
radiotherapy on sarcoma-180 were different
from those seen in the whole body. In both
instances, the additional effect ofactinomycin
D resembled the maximal effect of either
treatment alone. It was found that actino-
mycin D enhanced the radiation effect on
tumour growth when it was given 3-4 h
either before or after irradiation. Actino-
mycin D treatment or combined therapy
indicated that actinomycin D alone had little
effect on cell loss rate from labelled tumours.
Combined therapy did not significantly alter
the increased rate of cell loss observed for
radiotherapy alone, yet combined therapy
appeared to cause the enhanced cell loss rate
to be prolonged in comparison with radio-
therapy alone.
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DIFFERENTIAL EFFECT BETWEEN
THESE TISSUES RELATED TO
DRUG AND GAMMA-RAY FRAC-
TIONATION SCHEMES. A. WAM-
BERSIE, H. MAISIN, M. VAN DER PERRE and
M. R. SMOES, Radiotherapy Unit, Tumour
Centre, Capucienenvoer, Louvain.
Combination of irradiaton and 5-FU was
proved clinically to be of interest in the
treatment of malignant tumours, in parti-
cular of the gastrointestinal tract. The
possibility of achieving a differential effect
between several tissues as a function of
fractionation of drug and irradiation (60Co)
was investigated.
Three biological criteria were studied in
mice: intestinal death (LD50/5) after abdomen
irradiation, bone marrow death (LD50/30)
after total body irradiation and the response
of a Landschuts tumour grown in a solid or
ascitic form. Total 5-FU doses of 75 or
150 mg/kg were administered i.p.
For LD50/5, 5 equal daily injections, on
Day 5 to 1 before irradiation, were more
efficient than a single injection 3 days before
irradiation. The contrary was observed for
LD50/30, suggesting a differential effect
between these 2 normal tissues related to
5-FU fractionation. The first results on
Landschuts tumours are similar to those
observed for LD50/5. On the investigated
tissues, 2 i.p. injections of 5-FU 18 and 9 h
before irradiation were less efficient.
D2-D1 was studied for an interval of31 h,
24 h and 4 days between the fractions of
60Co. For LD50/5 and LD50/30, D2-D1 was
not significantly reduced after 5 injections of
5-FU (75 mg total dose) taking into account
the reduction of size of the gamma fractions.
RADIATION AND DRUGS; VARIOUS
MECHANISMS OF INTERACTION.
L. M. VAN PUTTEN, Radiobiological Institute
TNO, Rijswijk.
Various mechanisms were studied in
which combination of radiation and drugs
could be more effective than adding more
radiation, and model systems were developed
to identify these mechanisms.
Interaction ofdrugs and radiation leading
tosensitization couldoccur through oneofthe
following mechanisms: (a) interaction due to
presence of the drug during exposures, (b)
interference with repair, (c) differential
effectiveness of drugs on tumour and host
cells through different degrees of cell kinetic
response to radiation (recruitment) in these
2 systems.
The mechanism oftype (a) was studied for
hypoxic sensitizers on a poorly reoxygenating
mouse osteosarcoma. It was found that
metronidazole and Ro-07-0582 had a more
than additive effect on this tumour when
combined with fractionated radiotherapy.
Mechanisms oftype a, b and c were studied in
normal mouse haemopoietic stem cells.
None of the agents tested was effective by
mechanism (a) on well oxygenated haemo-
poietic stem cells. For 5-FU and vinblastine
an effectiveness by mechanism (b) could be
confirmed and many drugs were effective by
mechanism (c). However, the limitation of
the analysis to crmal tissue made it im-
possible to identify a gain of effectiveness on
tumours compared with normal tissues.
It seems unlikely that all clinical tumours
may be influenced equally by combination
therapy and it will be necessary to identify
the various categories of tumour radiation
resistance in order to apply the optimal type
of combination therapy.
Work supported under contract NO1-
CM-53763 by the National Cancer Institute
USA.
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RADIOPROTECTIVE EFFECT OF
WR 2721 IN COMBINED INJURED
MICE (X-IRRADIATION AND SKIN
LESION). F. VERSPOHL and 0. MESSER-
SCHMIDT, Laboratorium fur Experimentelle
Radiologie, Neuherberg bei Miinchen.
The protective effect ofthe thiophosphate
compound WR 2721, resulting in a reduction
of radiation lethality in mammals, is well
known. The effectivity of protective agents
afterinfliction ofirradiation and an additional
wound or other kind of stress on animals has
not yet been investigated.
In our investigations female mice were
given x-irradiation and an open dorsal
wound was made 2 or 8 days after irradiation.